glp 1 euglycemic dka diabetic ketoacidosis: A missed diagnosis Recommendations for action in practice

Phosphodiesterase-5 (PDE5) inhibitors such as sildenafil are often effective first-line treatments and are generally safe to use alongside GLP-1 medications, though they are contraindicated with nitrate medications and riociguat, and should be used with caution in unstable cardiovascular disease or if taking alpha-blockers

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

The agonist binds with its receptor GLP-1 (Glucagon like pepetide) and GlP (Glucose dependent insulinotropic polypetide which stimulates the release of insulin and stops the release of glucagon

Statements Author contributions EJ conducted the literature search, summarized these data, and drafted the review

Erick Singley (Clinical Core Laboratory, Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism) for technical support during sample analyses